SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending after achieving its first-ever quarterly profit amidst strong delivery growth, sparking fervent community discussion about a potential short squeeze and its long-term undervaluation given its unique battery swap technology and new chip innovations.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is seeing extreme volatility as crude oil prices first surged on escalating Middle East tensions and potential Strait of Hormuz disruptions, then sharply reversed following Donald Trump's comments suggesting the Iran conflict is "very complete" and supply concerns are easing. The community is actively debating whether this represents a "rug pull" and a market top, or if it's a temporary dip before another rebound amid lingering geopolitical risks.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending due to its approved $30M acceleration program for the Tanbreez HREE project and an analyst upgrade, which is fueling community discussion about its short squeeze potential. Investors are anticipating a favorable Bankable Feasibility Study update, focusing on the critical minerals sector's strategic importance, Greenland's heavy rare earths, and the project's 100% allocated initial production for Western supply chains.

Hydrograph Clean Power, Inc. engages in the research, development, marketing and commercialization of patented technology to produce pristine graphene, graphene derivatives and services. The company was founded by Harold Charles Davidson on June 26, 2017 and is headquartered in Vancouver, Canada.

Hydrograph Clean Power Inc

Hydrograph Clean Power is trending due to widespread anticipation of major commercial contracts and an upcoming NASDAQ uplisting, following recent global regulatory approvals for its high-purity graphene technology. The community is actively discussing its potential to revolutionize industries from defense to semiconductors, while debating its current valuation against long-term growth prospects.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc is trending after recent analyst upgrades and positive sentiment from its Barclays conference, where CEO Chuck Divita highlighted AI integration and a clear strategy for BetterHelp's turnaround with insurance and international growth. The community is actively discussing the company's perceived undervaluation and potential for a short squeeze as management focuses on execution.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending after reporting strong financial results that exceeded analyst expectations, signaling a shift to profitability driven by accelerating sales of its rare disease drug, MIPLYFFA. The community is actively discussing the company's undervalued status and speculating on upcoming catalysts, including potential European regulatory approval and a strategic acquisition.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is a top trending stock ahead of its crucial earnings report, sparking a fierce debate among investors over whether its substantial AI infrastructure investments will fuel significant cloud growth or exacerbate concerns about its rising debt and negative free cash flow. Conflicting reports regarding data center expansion plans with OpenAI and potential layoffs have further amplified market volatility and option activity.

CitroTech, Inc. is an integrated environmental service company, which engages in the provision of field services, remediation transportation, and EHS compliance services. It also offers on-site technical services, on-site and off-site treatment for hazardous and non-hazardous waste. The company was founded on March 14, 1990 and is headquartered in Cheyenne, WY.

CitroTech Inc.

CitroTech Inc. (CITR) is gaining attention as its CEO presents at the iAccess Alpha conference, driving community interest in the low-float stock's fire-retardant technology, which traders believe has significant potential in the growing market for fire prevention materials.

Carnival Corp. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corp. - Ordinary Shares (Paired Stock)

Carnival Corp

Carnival (CCL) is a hot topic as escalating Middle East tensions and oil price volatility create headwinds for the travel sector, but the community is largely bullish, highlighting the company's record bookings, strong revenues, and reinstated dividend as reasons to buy on dips.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

ProShares Ultra Bloomberg Natural Gas (BOIL) is seeing intense trading activity amidst escalating Middle East tensions, with disruptions in the Strait of Hormuz and a halt in Qatar's major LNG production sparking a debate between those anticipating a sustained price surge and others highlighting high US inventories and seasonal demand weakness.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$DGNMF 

https://www.reddit.com/r/pennystocks/s/U8u2DS80o6

[Warning] Banned from QIMC Discord for asking about the DMED healthcare-to-hydrogen pivot (after CEO promised transparency)

I am posting this to warn current and potential investors about the extreme censorship in the QIMC / DiagnaMed (DMED) Discord community. Despite receiving a direct DM from CEO John Karagiannidis apologizing for prior moderation issues and promising transparency, I was banned immediately for asking a fundamental due diligence question regarding the company’s pivot and dual leadership structure.

I have been researching the relationship between Quebec Innovative Materials Corp (QIMC) and DiagnaMed (DMED). Specifically, I wanted to understand the transition of DMED from a healthcare technology company (AI/Diagnostics) to a &quot;natural hydrogen&quot; play, and how the dual-CEO role (John K leading both entities) impacts strategy.

Reddit

StockTwits For Android 

Diagnamed Holdings Corp



[Warning] Banned from QIMC Discord for asking about the DMED healthcare-to-hydrogen pivot (after CEO promised transparency)

I am posting this to warn current and potential investors about the extreme censorship in the QIMC / DiagnaMed (DMED) Discord community. Despite receiving a direct DM from CEO John Karagiannidis apologizing for prior moderation issues and promising transparency, I was banned immediately for asking a fundamental due diligence question regarding the company’s pivot and dual leadership structure.

I have been researching the relationship between Quebec Innovative Materials Corp (QIMC) and DiagnaMed (DMED). Specifically, I wanted to understand the transition of DMED from a healthcare technology company (AI/Diagnostics) to a "natural hydrogen" play, and how the dual-CEO role (John K leading both entities) impacts strategy.

Dominic Reiss

My Question (Paraphrased): &quot;Can management outline the timeline and rationale for DiagnaMed’s transition from healthcare technology to a focus on natural hydrogen and energy IP? How and when was this pivot formalized in corporate filings, and how does the dual leadership arrangement (John K as CEO of both) support the long-term strategy?&quot;

I was banned. No warning, no answer, just an immediate ban.

 It is a major red flag for investors when:
A company pivots sectors (Healthcare -&gt; Energy) and refuses to answer questions about the timeline or rationale.

The claimed CEO in this discord privately claims to value transparency but the public forum is aggressively sanitized of any complex questions.

Investors are prevented from discussing the dual-role leadership structure.

If you are in the QIMC or DMED Discord, be aware that you are likely in a curated echo chamber where legitimate due diligence is treated as FUD.

My Question (Paraphrased): "Can management outline the timeline and rationale for DiagnaMed’s transition from healthcare technology to a focus on natural hydrogen and energy IP? How and when was this pivot formalized in corporate filings, and how does the dual leadership arrangement (John K as CEO of both) support the long-term strategy?"

I was banned. No warning, no answer, just an immediate ban.

 It is a major red flag for investors when:
A company pivots sectors (Healthcare -> Energy) and refuses to answer questions about the timeline or rationale.

The claimed CEO in this discord privately claims to value transparency but the public forum is aggressively sanitized of any complex questions.

Investors are prevented from discussing the dual-role leadership structure.

If you are in the QIMC or DMED Discord, be aware that you are likely in a curated echo chamber where legitimate due diligence is treated as FUD.

@domom I was the moderator who banned that account. It wasn’t for asking questions. It was banned for the attitude. The tone was aggressive and they were threatening mods, the discord is a discussion group run by volunteers and nobody is owed anything and if the rules of the community aren’t followed or there is any abuse of members or moderators then that user will be banned.

StockTwits for iOS

 I was the moderator who banned that account. It wasn’t for asking questions. It was banned for the attitude. The tone was aggressive and they were threatening mods, the discord is a discussion group run by volunteers and nobody is owed anything and if the rules of the community aren’t followed or there is any abuse of members or moderators then that user will be banned.

Alex Tobler

@domom  
I am shooting from older memory here. Back when Fabio Chianelli was near FDA approval with Pharmather, researching him, I saw he was a serial entrepreneur, and was even selling or leasing some sort of storage containers. And he was CEO of DiagnaMed. Brain health. I think they even had some other odd thing, too. DiagnaMed was a company in search of a market to enter. Fabio appears to have worked with his friends to enter the hydrogen market as well. Fabio stepped down as CEO of DiagnaMed (he&#39;s still on the Board) to focus on Pharmather, and they got John to be their CEO. I saw that DiagnaMed looked to really have a serious future, and they were posting on x.com some great news, regularly. Thinking they&#39;d actually found a very promising market, were going for it, had a top guy leading the company now, and were as yet basically unknown, I bought in. I was the first follower on StockTwits. Then I bought into Quebec Innovative. That is what I can share.

X (formerly Twitter)

StockTwits Web

  
I am shooting from older memory here. Back when Fabio Chianelli was near FDA approval with Pharmather, researching him, I saw he was a serial entrepreneur, and was even selling or leasing some sort of storage containers. And he was CEO of DiagnaMed. Brain health. I think they even had some other odd thing, too. DiagnaMed was a company in search of a market to enter. Fabio appears to have worked with his friends to enter the hydrogen market as well. Fabio stepped down as CEO of DiagnaMed (he's still on the Board) to focus on Pharmather, and they got John to be their CEO. I saw that DiagnaMed looked to really have a serious future, and they were posting on 

 some great news, regularly. Thinking they'd actually found a very promising market, were going for it, had a top guy leading the company now, and were as yet basically unknown, I bought in. I was the first follower on StockTwits. Then I bought into Quebec Innovative. That is what I can share.